Sonoma Pharmaceuticals
SNOA
#10305
Rank
NZ$6.97 M
Marketcap
NZ$4.03
Share price
-8.67%
Change (1 day)
15.72%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2025 (TTM): -NZ$5.37 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are NZ$16.93 Million. In 2024 the company made an earning of -NZ$7.57 Million a decrease over its 2023 earnings that were of -NZ$7.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$5.37 Million-29.07%
2024 -NZ$7.57 Million0.54%
2023 -NZ$7.53 Million-31.5%
2022 -NZ$10.98 Million16.86%
2021 -NZ$9.4 Million194.32%
2020 -NZ$3.2 Million-58.76%
2019 -NZ$7.74 Million-65.66%
2018 -NZ$22.55 Million4.84%
2017 -NZ$21.51 Million-2.17%
2016 -NZ$21.98 Million32.12%
2015 -NZ$16.64 Million-307.74%
2014 NZ$8 M-197.5%
2013 -NZ$8.22 Million
2010 -NZ$12.84 Million-14.02%
2009 -NZ$14.93 Million-57.28%
2008 -NZ$34.94 Million-8.03%
2007 -NZ$37.99 Million3.85%
2006 -NZ$36.58 Million39.31%
2005 -NZ$26.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.28 Billion 5,013.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$30.77 Million 482.11%๐Ÿ‡บ๐Ÿ‡ธ USA